Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-22-104798
Filing Date
2022-09-30
Accepted
2022-09-30 21:50:17
Documents
1
Period of Report
2022-09-28

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2227191-10_4seq1.html 4  
1 OWNERSHIP DOCUMENT tm2227191-10_4seq1.xml 4 12459
  Complete submission text file 0001104659-22-104798.txt   13835
Mailing Address 505 EAGLEVIEW BOULEVARD SUITE 212 EXTON PA 19341
Business Address 505 EAGLEVIEW BOULEVARD SUITE 212 EXTON PA 19341 4843481600
IDERA PHARMACEUTICALS, INC. (Issuer) CIK: 0000861838 (see all company filings)

IRS No.: 043072298 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address
Business Address
WOOTEN RONALD J (Reporting) CIK: 0001248723 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-31918 | Film No.: 221285735